Delirium and Neurocognitive Disorders

Howard CH Khoe; Cheryl WL Chang; Cyrus SH Ho

doi:10.1017/9781009458634.021

Case 21: - Delirium and Neurocognitive Disorders

from Part 1: - Vignettes

Published online by Cambridge University Press: 04 September 2025

Howard CH Khoe ,

Cheryl WL Chang and

Cyrus SH Ho

Show author details

Howard CH Khoe: Affiliation:
National Psychiatry Residency Programme, Singapore
Cheryl WL Chang: Affiliation:
National University Hospital, Singapore
Cyrus SH Ho: Affiliation:
National University Hospital, Singapore

Book contents

Get access

Summary

Chapter 21 covers the topic of delirium and neurocognitive disorders. Through a case vignette with topical MCQs for consolidation of learning, readers are brought through the diagnosis and treatment of a patient with delirium and neurocognitive disorder. Topics covered include diagnosis, mild and major neurocognitive disorders, types of neurocognitive disorders, risk factors for Alzheimer’s disease, instruments used in evaluation, investigations, pharmacological and non-pharmacological management of neurocognitive disorders, adverse effects of medications, delirium and its diagnosis, pharmacological and non-pharmacological management of delirium, and beahvioural and psychological symptoms of dementia.

Keywords

altered mental state Alzheimer’s disease delirium Lewy body dementia neurocognitive disorders vascular dementia

Information

Type: Chapter
Information: Practise Psychiatry
A Guide Through Vignettes and MCQs
, pp. 191 - 215

DOI: https://doi.org/10.1017/9781009458634.021 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/en Google Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsm Google Scholar

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.CrossRef Google Scholar

Castellano, JM, Kim, J, Stewart, FR, Jiang, H, DeMattos, RB, Patterson, BW, et al. Human APOE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med. 2011 Jun 29;3(89):89ra57.CrossRef Google Scholar PubMed

Farrer, LA, Cupples, LA, Haines, JL, Hyman, B, Kukull, WA, Mayeux, R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997 Oct 22;278(16):1349–56.10.1001/jama.1997.03550160069041CrossRef Google Scholar PubMed

Laurin, D, Verreault, R, Lindsay, J, MacPherson, K, Rockwood, K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001 Mar 1;58(3). Available from: http://archneur.jamanetwork.com/article.aspx?doi=10.1001/archneur.58.3.498 CrossRef Google Scholar PubMed

Hodkinson, HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233–8.10.1093/ageing/1.4.233CrossRef Google Scholar PubMed

Hazan, E, Frankenburg, F, Brenkel, M, Shulman, K. The test of time: a history of clock drawing. Int J Geriatr Psychiatry. 2018 Jan;33(1):e22–30.CrossRef Google Scholar

Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98.Google Scholar PubMed

Nasreddine, ZS, Phillips, NA, Bédirian, V, Charbonneau, S, Whitehead, V, Collin, I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695–9.10.1111/j.1532-5415.2005.53221.xCrossRef Google Scholar

Mathuranath, PS, Nestor, PJ, Berrios, GE, Rakowicz, W, Hodges, JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000 Dec 12;55(11):1613–20.CrossRef Google Scholar PubMed

Crum, RM, Anthony, JC, Bassett, SS, Folstein, MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993 May 12;269(18):2386–91.10.1001/jama.1993.03500180078038CrossRef Google Scholar PubMed

Tsoi, KKF, Chan, JYC, Hirai, HW, Wong, SYS, Kwok, TCY. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450–8.CrossRef Google Scholar PubMed

Tombaugh, TN, McIntyre, NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992 Sep;40(9):922–35.10.1111/j.1532-5415.1992.tb01992.xCrossRef Google Scholar PubMed

Knopman, DS, DeKosky, ST, Cummings, JL, Chui, H, Corey-Bloom, J, Relkin, N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 May 8;56(9):1143–53.10.1212/WNL.56.9.1143CrossRef Google Scholar

Woods, B, Aguirre, E, Spector, AE, Orrell, M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD005562.Google Scholar

Graff, MJL, Vernooij-Dassen, MJM, Thijssen, M, Dekker, J, Hoefnagels, WHL, Rikkert, MGMO. Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ. 2006 Dec 9;333(7580):1196.CrossRef Google Scholar PubMed

White, H. Weight change in Alzheimer’s disease. J Nutr Health Aging. 1998;2(2):110–2.Google Scholar PubMed

Forbes, D, Forbes, SC, Blake, CM, Thiessen, EJ, Forbes, S. Exercise programs for people with dementia. Cochrane Database Syst Rev. 2015 Apr 15;2015(4):CD006489.Google Scholar PubMed

Teri, L, Gibbons, LE, McCurry, SM, Logsdon, RG, Buchner, DM, Barlow, WE, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003 Oct 15;290(15):2015–22.CrossRef Google Scholar PubMed

Pitkälä, KH, Pöysti, MM, Laakkonen, ML, Tilvis, RS, Savikko, N, Kautiainen, H, et al. Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX): a randomized controlled trial. JAMA Intern Med. 2013 May 27;173(10):894–901.CrossRef Google Scholar PubMed

National Institute for Health and Care Excellence (NICE). Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. Technology appraisal guidance [TA217]. NICE; 2011. Available from: www.nice.org.uk/guidance/ta217 Google Scholar

Sano, M, Ernesto, C, Thomas, RG, Klauber, MR, Schafer, K, Grundman, M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. N Engl J Med. 1997 Apr 24;336(17):1216–22.10.1056/NEJM199704243361704CrossRef Google Scholar PubMed

Farina, N, Llewellyn, D, Isaac, MGEKN, Tabet, N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Database Syst Rev. 2017 Jan 27;2017(1):CD002854.Google Scholar

Birks, J, Grimley Evans, J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD003120.Google Scholar

DeKosky, ST, Williamson, JD, Fitzpatrick, AL, Kronmal, RA, Ives, DG, Saxton, JA, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008 Nov 19;300(19):2253–62.10.1001/jama.2008.683CrossRef Google Scholar PubMed

Cummings, JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry. 2003;11(2):131–45.10.1097/00019442-200303000-00004CrossRef Google Scholar PubMed

Clark, CM, Karlawish, JHT. Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med. 2003 Mar 4;138(5):400–10.10.7326/0003-4819-138-5-200303040-00010CrossRef Google Scholar PubMed

Wei, LA, Fearing, MA, Sternberg, EJ, Inouye, SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc. 2008 May;56(5):823–30.10.1111/j.1532-5415.2008.01674.xCrossRef Google Scholar

Burns, A. Delirium. J Neurol, Neurosurg Psychiatry. 2004 Mar 1;75(3):362–7.CrossRef Google Scholar PubMed

Mega, MS, Cummings, JL, Fiorello, T, Gornbein, J. The spectrum of behavioral changes in Alzheimer’s disease. Neurology. 1996 Jan;46(1):130–5.CrossRef Google Scholar PubMed

Lyketsos, CG, Steinberg, M, Tschanz, JT, Norton, MC, Steffens, DC, Breitner, JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000 May;157(5):708–14.10.1176/appi.ajp.157.5.708CrossRef Google Scholar

Lyketsos, CG, Lopez, O, Jones, B, Fitzpatrick, AL, Breitner, J, DeKosky, S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002 Sep 25;288(12):1475–83.CrossRef Google Scholar PubMed

Gallagher-Thompson, D, Brooks, JO, Bliwise, D, Leader, J, Yesavage, JA. The relations among caregiver stress, “sundowning” symptoms, and cognitive decline in Alzheimer’s disease. J Am Geriatr Soc. 1992 Aug;40(8):807–10.10.1111/j.1532-5415.1992.tb01853.xCrossRef Google Scholar PubMed

Zarit, SH, Reever, KE, Back-Peterson, J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980;20:649–55.CrossRef Google Scholar

Atypical antipsychotics in the elderly. Med Lett Drugs Ther. 2005 Aug 1;47(1214):61–2.Google Scholar

Kuehn, BM. FDA warns antipsychotic drugs may be risky for elderly. JAMA. 2005 May 25;293(20):2462.Google Scholar PubMed

Porsteinsson, AP, Drye, LT, Pollock, BG, Devanand, DP, Frangakis, C, Ismail, Z, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014 Feb 19;311(7):682–91.10.1001/jama.2014.93CrossRef Google Scholar PubMed

Pollock, BG, Mulsant, BH, Rosen, J, Sweet, RA, Mazumdar, S, Bharucha, A, et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry. 2002 Mar;159(3):460–5.CrossRef Google Scholar PubMed

Qiu, C, Kivipelto, M, von Strauss, E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111–28.10.31887/DCNS.2009.11.2/cqiuCrossRef Google Scholar PubMed

Goldman, JS, Hahn, SE, Catania, JW, LaRusse-Eckert, S, Butson, MB, Rumbaugh, M, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011 Jun;13(6):597–605.10.1097/GIM.0b013e31821d69b8CrossRef Google Scholar PubMed

Slooter, AJC, Cruts, M, Hofman, A, Koudstaal, PJ, van der Kuip, D, de Ridder, M a. J, et al. The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study. Neurology. 2004 Apr 13;62(7):1196–8.10.1212/01.WNL.0000118302.66674.E1CrossRef Google Scholar PubMed

Myers, RH, Schaefer, EJ, Wilson, PW, D’Agostino, R, Ordovas, JM, Espino, A, et al. Apolipoprotein E epsilon4 association with dementia in a population-based study: the Framingham study. Neurology. 1996 Mar;46(3):673–7.CrossRef Google Scholar

Birks, J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593.Google Scholar PubMed

Courtney, C, Farrell, D, Gray, R, Hills, R, Lynch, L, Sellwood, E, et al. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet. 2004 Jun 26;363(9427):2105–15.Google Scholar PubMed

Ballard, C, Hanney, ML, Theodoulou, M, Douglas, S, McShane, R, Kossakowski, K, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009 Feb;8(2):151–7.CrossRef Google Scholar PubMed

American Geriatrics Society Ethics Committee and Clinical Practice and Models of Care Committee. American Geriatrics Society feeding tubes in advanced dementia position statement. J Am Geriatr Soc. 2014 Aug;62(8):1590–3.Google Scholar

Finucane, TE. Malnutrition, tube feeding and pressure sores: data are incomplete. J Am Geriatr Soc. 1995 Apr;43(4):447–51.10.1111/j.1532-5415.1995.tb05822.xCrossRef Google Scholar PubMed

Finucane, TE, Bynum, JP. Use of tube feeding to prevent aspiration pneumonia. Lancet. 1996 Nov 23;348(9039):1421–4.10.1016/S0140-6736(96)03369-7CrossRef Google Scholar PubMed

Accessibility standard: Inaccessible, or known limited accessibility

The PDF of this book is known to have missing or limited accessibility features. We may be reviewing its accessibility for future improvement, but final compliance is not yet assured and may be subject to legal exceptions. If you have any questions, please contact accessibility@cambridge-org.demo.remotlog.com.

Content Navigation

Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.

Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.

Reading Order & Textual Equivalents

Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.

Short alternative textual descriptions
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.

Visual Accessibility

Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.

Structural and Technical Features

ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.